This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Citalopram and Clozapine: Potential Drug Interaction

Christina P. Borba and David C. Henderson

Published: September 30, 2000

Article Abstract

Letter to the Editor

Sir: Clozapine, an atypical antipsychotic agent, appears to
be metabolized, in part, by the cytochrome P450 (CYP) 1A2
and CYP3A3/4 enzymes. Clozapine’s side effects include sedation,
hypersalivation, constipation, seizures, weight-gain, and
clozapine-induced agranulocytosis. Citalopram is a newly released
selective serotonin reuptake inhibitor (SSRI) that is
thought to have a favorable drug interaction profile secondary to
weak or negligible inhibition of cytochrome P450 enzymes.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Psychopharmacology

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...